Kubo, Toshio - OU Author List - OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY

CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

FullText URL	fulltext.pdf
Author	Hara, Naofumi\| Ichihara, Eiki\| Kano, Hirohisa\| Ando, Chihiro\| Morita, Ayako\| Nishi, Tatsuya\| Okawa, Sachi\| Nakasuka, Takamasa\| Hirabae, Atsuko\| Abe, Masaya\| Asada, Noboru\| Ninomiya, Kiichiro\| Makimoto, Go\| Fujii, Masanori\| Kubo, Toshio\| Ohashi, Kadoaki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	Epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) cell cycle CDK4/6 inhibitor
Published Date	2023-10-31
Publication Title	Translational Lung Cancer Research
Volume	volume12
Issue	issue10
Publisher	AME Publishing Company
ISSN	2218-6751
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© Translational Lung Cancer Research.
File Version	publisher
PubMed ID	38025818
DOI	10.21037/tlcr-23-99
Web of Science KeyUT	001091030600001
Related Url	isVersionOf https://doi.org/10.21037/tlcr-23-99

Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embolization

FullText URL	fulltext.pdf
Author	Taoka, Masataka\| Makimoto, Go\| Umakoshi, Noriyuki\| Ninomiya, Kiichiro\| Higo, Hisao\| Kato, Yuka\| Fujii, Masanori\| Kubo, Toshio\| Ichihara, Eiki\| Ohashi, Kadoaki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	Hemoptysis Bronchial artery embolization Endoscopic bronchial occlusion Endobronchial Watanabe Spigot
Published Date	2022
Publication Title	Respiratory Medicine Case Reports
Volume	volume38
Publisher	Elsevier
Start Page	101669
ISSN	2213-0071
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2022 The Authors.
File Version	publisher
PubMed ID	35646587
DOI	10.1016/j.rmcr.2022.101669
Web of Science KeyUT	001089212200003
Related Url	isVersionOf https://doi.org/10.1016/j.rmcr.2022.101669

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer

FullText URL	fulltext.pdf
Author	Ando, Chihiro\| Ichihara, Eiki\| Nishi, Tatsuya\| Morita, Ayako\| Hara, Naofumi\| Takada, Kenji\| Nakasuka, Takamasa\| Watanabe, Hiromi\| Kano, Hirohisa\| Nishii, Kazuya\| Makimoto, Go\| Kondo, Takumi\| Ninomiya, Kiichiro\| Fujii, Masanori\| Kubo, Toshio\| Ohashi, Kadoaki\| Matsuoka, Ken-Ichi\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	alectinib ALK gilteritinib non-small cell lung cancer TKI
Published Date	2023-09-15
Publication Title	Cancer Science
Volume	volume114
Issue	issue11
Publisher	Wiley
Start Page	4343
End Page	4354
ISSN	1347-9032
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 The Authors.
File Version	publisher
PubMed ID	37715310
DOI	10.1111/cas.15958
Web of Science KeyUT	001067479000001
Related Url	isVersionOf https://doi.org/10.1111/cas.15958

PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer

FullText URL	fulltext20230421-01.pdf figure20230421-01.pdf
Author	Nakasuka, Takamasa\| Ohashi, Kadoaki\| Nishii, Kazuya\| Hirabae, Atsuko\| Okawa, Sachi\| Tomonobu, Nahoko\| Takada, Kenji\| Ando, Chihiro\| Watanabe, Hiromi\| Makimoto, Go\| Ninomiya, Kiichiro\| Fujii, Masanori\| Kubo, Toshio\| Ichihara, Eiki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Kumon, Hiromi\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	EGFR mutation Non-small cell lung cancer Antitumor immunity Non-inflamed tumor Ad-SGE-REIC Gene therapy PD-1
Note	©2023 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at https://doi.org/10.1016/j.lungcan.2023.01.018.\| This fulltext file will be available in Apr. 2024.\|
Published Date	2023-04
Publication Title	Lung Cancer
Volume	volume178
Publisher	Elsevier BV
Start Page	1
End Page	10
ISSN	0169-5002
NCID	AA10785743
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 Elsevier B.V.
File Version	author
PubMed ID	36753780
DOI	10.1016/j.lungcan.2023.01.018
Web of Science KeyUT	000931976300001
Related Url	isVersionOf https://doi.org/10.1016/j.lungcan.2023.01.018

Effect of a Cyclooxygenase-2 Inhibitor in Combination with (−)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice

JaLCDOI	10.18926/AMO/64363
FullText URL	77_1_65.pdf
Author	Sato, Ken\| Takigawa, Nagio\| Kubo, Toshio\| Katayama, Hideki\| Kishino, Daizo\| Okada, Toshiaki\| Hisamoto, Akiko\| Mimoto, Junko\| Ochi, Nobuaki\| Yoshino, Tadashi\| Ueoka, Hiroshi\| Tanimoto, Mitsune\| Maeda, Yoshionobu\| Kiura, Katsuyuki\|
Abstract	We investigated the effects of celecoxib combined with (−)-epigallocatechin-3-gallate (EGCG) or polyphenon E in a cisplatin-induced lung tumorigenesis model. Four-week-old female A/J mice were divided into seven groups: (i) Control, (ii) 150 mg/kg celecoxib (150Cel), (iii) 1,500 mg/kg celecoxib (1500Cel), (iv) EGCG+150 mg/kg celecoxib (EGCG+150Cel), (v) EGCG+1,500 mg/kg celecoxib (EGCG+1500Cel), (vi) polyphenon E+150 mg/kg celecoxib (PolyE+150Cel), and (vii) polyphenon E+1,500 mg/kg celecoxib (PolyE+1500Cel). All mice were administered cisplatin (1.62 mg/kg of body weight, i.p.) 1×/week for 10 weeks and sacrificed at week 30; the numbers of tumors on the lung surface were then determined. The tumor incidence and multiplicity (no. of tumors/mouse, mean±SD) were respectively 95% and 2.15±1.50 in Control, 95% and 2.10±1.29 in 150Cel, 86% and 1.67±1.20 in 1500Cel, 71% and 1.38±1.24 in EGCG+150Cel, 67% and 1.29±1.38 in EGCG+1500Cel, 80% and 1.95±1.36 in PolyE+150Cel, and 65% and 1.05±0.10 in PolyE+1500Cel. The combination of high-dose celecoxib with EGCG or polyphenon E significantly reduced multiplicity in cisplatin-induced lung tumors.
Keywords	celecoxib cisplatin EGCG lung tumor polyphenon E
Amo Type	Original Article
Publication Title	Acta Medica Okayama
Published Date	2023-02
Volume	volume77
Issue	issue1
Publisher	Okayama University Medical School
Start Page	65
End Page	70
ISSN	0386-300X
NCID	AA00508441
Content Type	Journal Article
language	English
Copyright Holders	Copyright Ⓒ 2023 by Okayama University Medical School
File Version	publisher
Refereed	True
PubMed ID	36849147
Web of Science KeyUT	000952992100004

Chemopreventive effects and anti-tumorigenic mechanisms of Actinidia arguta, known as sarunashi in Japan toward 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)- induced lung tumorigenesis in a/J mouse

FullText URL	fulltext20221227-2.pdf
Author	Takata, Jun\| Miyake, Naoko\| Saiki, Yusuke\| Tada, Misako\| Sasaki, Kensuke\| Kubo, Toshio\| Kiura, Katsuyuki\| Arimoto-Kobayashi, Sakae\|
Keywords	Akt signal transduction Lung tumorigenesis Anti-mutagenesis DNA methylation Tobacco-specific nitrosamine Isoquercetin
Published Date	2022-12-09
Publication Title	Genes and Environment
Volume	volume44
Issue	issue1
Publisher	Springer Science and Business Media LLC
Start Page	26
ISSN	1880-7062
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© The Author(s) 2022.
File Version	publisher
PubMed ID	36494703
DOI	10.1186/s41021-022-00255-0
Web of Science KeyUT	000896571200001
Related Url	isVersionOf https://doi.org/10.1186/s41021-022-00255-0

Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case Report

FullText URL	fulltext.pdf
Author	Makimoto, Go\| Shimonishi, Atsushi\| Ohashi, Kadoaki\| Ninomiya, Kiichiro\| Higo, Hisao\| Kato, Yuka\| Fujii, Masanori\| Kubo, Toshio\| Ichihara, Eiki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	MET Tepotinib Non-small-cell lung cancer
Published Date	2022
Publication Title	Case Reports In Oncology
Volume	volume15
Issue	issue2
Publisher	Karger
Start Page	494
End Page	498
ISSN	1662-6575
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2022 The Author(s).
File Version	publisher
PubMed ID	35702678
DOI	10.1159/000524326
Web of Science KeyUT	000864085100005
Related Url	isVersionOf https://doi.org/10.1159/000524326

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

FullText URL	fulltext.pdf
Author	Ando, Eri\| Nakasuka, Takamasa\| Kubo, Toshio\| Taniguchi, Akihiko\| Ninomiya, Kiichiro\| Kato, Yuka\| Ichihara, Eiki\| Ohashi, Kadoaki\| Rai, Kammei\| Hotta, Katsuyuki\| Yamane, Masaomi\| Miyahara, Nobuaki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	pulmonary aspergilloma allergic bronchopulmonary aspergillosis disaster
Published Date	2022-02-01
Publication Title	Internal Medicine
Volume	volume61
Issue	issue3
Publisher	JAPAN SOC INTERNAL MEDICINE
Start Page	379
End Page	383
ISSN	0918-2918
NCID	AA10827774
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2022 The Japanese Society of Internal Medicine
File Version	publisher
PubMed ID	34373373
DOI	10.2169/internalmedicine.7124-21
Web of Science KeyUT	000752787300015
Related Url	isVersionOf https://doi.org/10.2169/internalmedicine.7124-21

Identification of targetable kinases in idiopathic pulmonary fibrosis

FullText URL	fulltext.pdf
Author	Higo, Hisao\| Ohashi, Kadoaki\| Tomida, Shuta\| Okawa, Sachi\| Yamamoto, Hiromasa\| Sugimoto, Seiichiro\| Senoo, Satoru\| Makimoto, Go\| Ninomiya, Kiichiro\| Nakasuka, Takamasa\| Nishii, Kazuya\| Taniguchi, Akihiko\| Kubo, Toshio\| Ichihara, Eiki\| Hotta, Katsuyuki\| Miyahara, Nobuaki\| Maeda, Yoshinobu\| Toyooka, Shinichi\| Kiura, Katsuyuki\|
Keywords	Idiopathic pulmonary fibrosis RNA sequencing Molecular therapeutic target Personalized therapy
Published Date	2022-02-07
Publication Title	Respiratory Research
Volume	volume23
Issue	issue1
Publisher	BMC
Start Page	20
ISSN	1465-993X
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© The Author(s) 2022.
File Version	publisher
PubMed ID	35130915
DOI	10.1186/s12931-022-01940-y
Web of Science KeyUT	000752386100002
Related Url	isVersionOf https://doi.org/10.1186/s12931-022-01940-y

Dramatic Response to Carboplatin Plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis

FullText URL	fulltext.pdf
Author	Oda, Naohiro\| Tabata, Masahiro\| Uno, Masatoshi\| Umeda, Yuzo\| Kato, Hironari\| Kubo, Toshio\| Senoo, Satoru\| Yagi, Takahito\| Fujiwara, Toshiyoshi\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	pancreas mucinous cystadenocarcinoma carboplatin paclitaxel
Published Date	2021-09-15
Publication Title	Internal Medicine
Volume	volume60
Issue	issue18
Publisher	The Japanese Society of Internal Medicine
Start Page	2967
End Page	2971
ISSN	0918-2918
NCID	AA10827774
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2021 The Japanese Society of Internal Medicine
File Version	publisher
PubMed ID	33814494
DOI	10.2169/internalmedicine.6730-20
Web of Science KeyUT	000697279400013
Related Url	isVersionOf https://doi.org/10.2169/internalmedicine.6730-20

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

FullText URL	fulltext.pdf
Author	Okawa, Sachi\| Rai, Kammei\| Fujii, Nobuharu\| Gion, Yuka\| Ninomiya, Kiichiro\| Kato, Yuka\| Taniguchi, Akihiko\| Kubo, Toshio\| Ichihara, Eiki\| Ohashi, Kadoaki\| Miyahara, Nobuaki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	EGFR IgG4-related disease marginal zone lymphoma osimertinib
Published Date	2021-09-01
Publication Title	Internal Medicine
Volume	volume60
Issue	issue17
Publisher	The Japanese Society of Internal Medicine
Start Page	2831
End Page	2837
ISSN	0918-2918
NCID	AA10827774
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2021 The Japanese Society of Internal Medicine
File Version	publisher
PubMed ID	33775999
DOI	10.2169/internalmedicine.6470-20
Web of Science KeyUT	000695856000020
Related Url	isVersionOf https://doi.org/10.2169/internalmedicine.6470-20

Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR‑mutant lung cancer with HIF‑1α/TGF‑α expression

FullText URL	fulltext20210810-3.pdf
Author	Nishii, Kazuya\| Ohashi, Kadoaki\| Watanabe, Hiromi\| Makimoto, Go\| Nakasuka, Takamasa\| Higo, Hisao\| Ninomiya, Kiichiro\| Kato, Yuka\| Kubo, Toshio\| Rai, Kammei\| Ichihara, Eiki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	epidermal growth factor receptor osimertinib bevacizumab cetuximab hypoxia‑inducible factor‑1α transforming growth factor‑α
Published Date	2021-7-7
Publication Title	Oncology Letters
Volume	volume22
Issue	issue3
Publisher	Spandidos Publications
Start Page	639
ISSN	1792-1074
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© Nishii et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
File Version	publisher
DOI	10.3892/ol.2021.12900
Web of Science KeyUT	000678494600001
Related Url	isVersionOf https://doi.org/10.3892/ol.2021.12900

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers

FullText URL	fulltext.pdf
Author	Watanabe, Hiromi\| Ichihara, Eiki\| Kayatani, Hiroe\| Makimoto, Go\| Ninomiya, Kiichiro\| Nishii, Kazuya\| Higo, Hisao\| Ando, Chihiro\| Okawa, Sachi\| Nakasuka, Takamasa\| Kano, Hirohisa\| Hara, Naofumi\| Hirabae, Atsuko\| Kato, Yuka\| Ninomiya, Takashi\| Kubo, Toshio\| Rai, Kammei\| Ohashi, Kadoaki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Published Date	2021-01-07
Publication Title	Cancer science
Publisher	Wiley
ISSN	1347-9032
NCID	AA11808050
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2021 The Authors.
File Version	publisher
PubMed ID	33410241
NAID	120007008532
DOI	10.1111/cas.14801
Web of Science KeyUT	000630136900001
Related Url	isVersionOf https://doi.org/10.1111/cas.14801

Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction

FullText URL	fulltext.pdf
Author	Nishii, Kazuya\| Ohashi, Kadoaki\| Tamura, Tomoki\| Ninomiya, Kiichiro\| Matsubara, Takehiro\| Senoo, Satoru\| Kano, Hirohisa\| Watanabe, Hiromi\| Oda, Naohiro\| Makimoto, Go\| Higo, Hisao\| Kato, Yuka\| Ninomiya, Takashi\| Kubo, Toshio\| Yamamoto, Hiromasa \| Tomida, Shuta\| Hotta, Katsuyuki\| Tabata, Masahiro\| Toyooka, Shinichi\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	non-small cell lung cancer epidermal growth factor receptor mutations droplet digital PCR exhaled breath condensate EGFR-TKIs
Published Date	2020-12
Publication Title	Oncology Letters
Volume	volume20
Issue	issue6
Publisher	Spandidos Publications
Start Page	393
ISSN	1792-1074
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
File Version	publisher
PubMed ID	33193853
DOI	10.3892/ol.2020.12256
Web of Science KeyUT	000595649300005
Related Url	isVersionOf https://doi.org/10.3892/ol.2020.12256

Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden

FullText URL	J_Thorac_Oncol_201907017.pdf
Author	Makimoto, Go\| Ohashi, Kadoaki\| Tomida, Shuta\| Nishii, Kazuya\| Matsubara, Takehiro\| Kayatani, Hiroe\| Higo, Hisao\| Ninomiya, Kiichiro\| Sato, Akiko\| Watanabe, Hiromi\| Kano, Hirohisa\| Ninomiya, Takashi\| Kubo, Toshio\| Rai, Kammei\| Ichihara, Eiki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Toyooka, Shinichi\| Takata, Minoru\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	ALK G1202R Alectinib Amphiregulin MET NSCLC
Published Date	2019-07-30
Publication Title	Journal of Thoracic Oncology
Volume	volume14
Issue	issue11
Publisher	Elsevier
Start Page	2009
End Page	2018
ISSN	15560864
NCID	AA12058455
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
File Version	author
PubMed ID	31374369
DOI	10.1016/j.jtho.2019.07.017
Web of Science KeyUT	000492678300025
Related Url	isVersionOf https://doi.org/10.1016/j.jtho.2019.07.017

Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation

JaLCDOI	10.18926/AMO/54499
FullText URL	70_4_243.pdf
Author	Osawa, Masahiro\| Ohashi, Kadoaki\| Kubo, Toshio\| Ichihara, Eiki\| Takata, Saburo\| Takigawa, Nagio\| Takata , Minoru\| Tanimoto, Mitsune\| Kiura, Katsuyuki\|
Abstract	Vandetanib (ZactimaTM) is a novel, orally available inhibitor of both vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor receptor (EGFR) tyrosine kinase. In the present study, a line of transgenic mice with a mouse Egfr gene mutation (delE748-A752) corresponding to a human EGFR mutation (delE746-A750) was established. The transgenic mice developed atypical adenomatous hyperplasia to adenocarcinoma of the lung at around 5 weeks of age and died of lung tumors at approximately 17 weeks of age. In the mice treated with vandetanib (6mg/kg/day), these lung tumors disappeared and the phosphorylations of EGFR and VEGFR-2 were reduced in lung tissues to levels comparable to those of non-transgenic control mice. The median overall survival time of the transgenic mice was 28 weeks in the vandetanib-treated group and 17 weeks in the vehicle-treated group. Vandetanib significantly prolonged the survival of the transgenic mice (log-rank test, p＜0.01); resistance to vandetanib occurred at 20 weeks of age and the animals died from their lung tumors at about 28 weeks of age. These data suggest that vandetanib could suppress the progression of tumors harboring an activating EGFR mutation.
Keywords	vandetanib VEGFR EGFR nonsmall cell lung cancer transgenic mouse
Amo Type	Original Article
Publication Title	Acta Medica Okayama
Published Date	2016-08
Volume	volume70
Issue	issue4
Publisher	Okayama University Medical School
Start Page	243
End Page	253
ISSN	0386-300X
NCID	AA00508441
Content Type	Journal Article
language	English
Copyright Holders	CopyrightⒸ 2016 by Okayama University Medical School
File Version	publisher
Refereed	True
PubMed ID	27549668
Web of Science KeyUT	000384748600003

HER2異常等の低頻度の分子異常を有する非小細胞肺癌の臨床病理学的特徴を明らかにするための前向き観察研究（HER2-CS Study）と標準化学療法後再発・増悪または標準化学療法不応性のHER2陽性非小細胞肺癌患者を対象としたトラスツズマブエムタンシン（遺伝子組換え）の第2相試験

Title Alternative	A prospective cohort study to define the clinical and pathological features of lung cancers harboring HER2 gene aberrations (the HER2-CS Study) and a phase II study of trastuzumab emtansine (recombinant) in patients with HER2-positive non-small cell lung cancer who recurred, progressed after standard chemotherapy, or were primarily refractory to standard chemotherapy
FullText URL	127_127.pdf
Author	Kiura, Katsuyuki\| Hotta, Katsuyuki\| Sato, Akiko\| Ohashi, Kadoaki\| Ninomiya, Takashi\| Minnami, Daisuke\| Tabata, Masahiro\| Kubo, Toshio\| Kato, Yuka\| Hirata, Taizo\|
Keywords	臨床研究中核病院国立研究開発法人日本医療研究開発機構文部科学省橋渡し研究加速ネットワークプログラム HER2-CS study trastuzumab emtansine
Publication Title	岡山医学会雑誌
Published Date	2015-08-03
Volume	volume127
Issue	issue2
Start Page	127
End Page	132
ISSN	0030-1558
Related Url	isVersionOf https://doi.org/10.4044/joma.127.127
language	Japanese
Copyright Holders	Copyright (c) 2015 岡山医学会
File Version	publisher
DOI	10.4044/joma.127.127
NAID	130005096256

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model

Author	Murakami, Toshi\| Takigawa, Nagio\| Ninomiya, Takashi\| Ochi, Nobuaki\| Yasugi, Masaaki\| Honda, Yoshihiro\| Kubo, Toshio\| Ichihara, Eiki\| Hotta, Katsuyuki\| Tanimoto, Mitsune\| Kiura, Katsuyuki\|
Published Date	2014-01
Publication Title	Lung Cancer
Volume	volume83
Issue	issue1
Content Type	Journal Article